Swietenidine B exhibits significant anti-inflammatory and analgesic properties, making it a promising candidate for the development of pain-relief and anti-inflammatory medications. It has been studied for its ability to modulate key inflammatory pathways, particularly through the inhibition of pro-inflammatory cytokines and enzymes such as COX-2 and TNF-α. Due to its natural origin and observed efficacy in preclinical models, it is being explored as a lead compound for treating chronic inflammatory conditions like arthritis and neuroinflammation. Additionally, preliminary research suggests potential neuroprotective effects, which could support its use in neurodegenerative disease research. Its application in traditional medicine validation also helps bridge ethnopharmacological knowledge with modern drug development.